Moving Beyond the Valley of Death: Regulation and Venture Capital Investments in Early-Stage Biopharmaceutical Firms
收藏NBER2018-10-01 更新2025-01-04 收录
下载链接：
https://www.nber.org/papers/w25202
下载链接
链接失效反馈官方服务：
资源简介：
Can regulation reduce risks associated with investing in early-stage firms? Using the passage of the European Orphan Drug Act (EU-ODA), we examine this question in the biopharmaceutical industry. We provide causal evidence that venture capitalists (VCs) are more likely to invest in early-stage firms
提供机构：
美国国家经济研究局
创建时间：
2018-10-01
